{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Sounds of Science","title":"A New Era for FOXG1: The Race to First‑in‑Human Trials ","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/0f7d957d\"></iframe>","width":"100%","height":180,"duration":1275,"description":"FOXG1 Research Foundation CEO Nasha Fitter returns to Sounds of Science with extraordinary updates: FDA Fast Track designation, IND clearance, and the first‑ever clinical trial for a FOX G1 gene therapy now within reach. In this episode, hear how science, community, and a mother’s determination are rewriting what’s possible.  Show Notes Cell and Gene Therapy CDMO Solutions | Charles River Viral Vector Manufacturing \\ Charles River AAV Production for Rare Disease Therapies: From Challenge to Solution | Webcast Rare Disease | Charles River Rare Disease Research for Drug Development | Charles River FOX G1: A Mom’s Mission | Podcast ","thumbnail_url":"https://img.transistorcdn.com/ZE2zIMlSzoDJ-xSt26RohDaQEx1CXFTXmgj7dMpX-dk/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hNjhm/NWQ0NDVmNDY1Njcw/NGJmMzBkMTg3OWQ3/MTdmYy5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}